Roger Lassing
Corporate Officer/Principal bij ICONOVO AB
Profiel
Roger Lassing is currently the Vice President of Business Development at Iconovo AB.
Previously, he held positions as Vice President at Takeda Pharmaceutical Co., Ltd., Vice President & Global Brand Manager at AstraZeneca AB, and Senior Manager of Global Business Development at LEO Pharma AB.
Lassing received his undergraduate degree and MBA from the University of Lund.
Actieve functies van Roger Lassing
| Bedrijven | Functie | Begin |
|---|---|---|
| ICONOVO AB | Corporate Officer/Principal | 01-01-2019 |
Eerdere bekende functies van Roger Lassing
| Bedrijven | Functie | Einde |
|---|---|---|
| LEO Pharma AB | Corporate Officer/Principal | - |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - |
Opleiding van Roger Lassing
| University of Lund | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ICONOVO AB | Health Technology |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
| LEO Pharma AB |
